Experimental Device to Evaluate Aerosol Dispersion in Venues

The COVID-19 pandemic has focused attention to the importance of understanding and mitigating the airborne transmission of pathogens in indoor environments. This study investigated the aerosol distribution in different indoor venues with varying ventilation concepts, including displacement, mixed, and natural ventilation. A measurement system was developed to investigate venue-specific aerosol distribution patterns using a sodium chloride solution as a tracer. To analyse the spatial dispersion of aerosols, Computational Fluid Dynamics (CFD) simulations were conducted in addition to experimental investigations. The investigations indicated the lowest aerosol load for the venue with displacement ventilation and the highest for the natural ventilated venue. The measurement system developed in this study provides a useful tool for assessing the effectiveness of ventilation measures in reducing airborne transmission of pathogens in indoor environments. It also proved its wide range of applications, as it can be used in various sized and shaped indoor environments, with or without an audience. ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement This work was supported by the Ministry of Science, Energy, Climate Protection and Environment of the Federal State of Saxony-Anhalt (grant number I 140), the Federal Government Commissioner for Culture and the Media (grant number 2521NSK115) and Berlin University Alliance (grant number SARS-CoV-2 Ausbreitung, Restart 2.0) as part of the RESTART 2.0 project. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Ethics Committee of the Martin Luther University (Halle, Germany) gave ethical approval for this work. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes The data that support the findings of this study are available from the corresponding author upon reasonable request.